MoneyWorks4Me

Medicamen Biotech informs about analyst meeting

24 Jan 2018 Evaluate

Pursuant to Regulation 30(6) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that few Analysts/ Individual and Institutional Investor/ Stock Broker would be visiting Bhiwadi Plant and Meeting with the Senior Management of the Company on Saturday the 27th day of January, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..